T1	Chemical 33 40	AZD6244 
T2	Chemical 19 30	selumetinib 
T3	Chemical 43 54	ARRY-142866 
T4	Gene_or_protein 61 67	MEK1/2 
T5	Disease 113 136	refractory solid tumors 
T6	Disease 141 170	KRAS mutant colorectal cancer 
T7	Gene_or_protein 141 145	KRAS 
T8	Chemical 61 77	MEK1/2 inhibitor
T9	Chemical 100 109	cetuximab
T10	Limited_variation 141 152	KRAS mutant
T11	Chemical 19 30;80 109	selumetinib in combination with cetuximab
R1	decreases Arg1:T2 Arg2:T4	
R2	isEquivalentTo Arg1:T1 Arg2:T2	
R3	isEquivalentTo Arg1:T3 Arg2:T2	
R4	treats Arg1:T11 Arg2:T6	
R5	treats Arg1:T11 Arg2:T5	
#1	AnnotatorNotes R4	hyp
#2	AnnotatorNotes R5	hyp
